Vertex Pharmaceuticals plans to sell a gene-editing treatment for sickle-cell disease. A patent on CRISPR could stand in the way.
The first CRISPR cure might kickstart the next big patent battle
Posted in biotech/medical, genetics
Posted in biotech/medical, genetics
Vertex Pharmaceuticals plans to sell a gene-editing treatment for sickle-cell disease. A patent on CRISPR could stand in the way.